Newhouse, United Kingdom

Susan Elizabeth Napier




Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Lanarkshire, GB (2010)
  • Newhouse, GB (2009 - 2011)

Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Susan Elizabeth Napier

Introduction

Susan Elizabeth Napier is a prominent inventor based in Newhouse, GB. She has made significant contributions to the field of pharmaceuticals, holding a total of six patents. Her work focuses on developing novel compounds that have therapeutic applications.

Latest Patents

Among her latest patents is a compound known as 2-(1-oxo-1H-isoquinolin-2-yl)acetamide derivative. This invention includes pharmaceutically acceptable salts or solvates, with specific substituents defined in the specification and claims. Additionally, she has developed pharmaceutical compositions that incorporate these derivatives for therapeutic use. Another notable patent involves 9-azabicyclo[3.3.1]nonane derivatives, which also includes pharmaceutically acceptable salts or solvates. This invention relates to pharmaceutical compositions that utilize these derivatives in therapy.

Career Highlights

Throughout her career, Susan has worked with notable companies such as N.V. Organon and Neurosearch A/S. Her experience in these organizations has contributed to her expertise in pharmaceutical innovation and development.

Collaborations

Some of her coworkers include Jeffrey John Letourneau and Michael H Ohlmeyer. Their collaboration has likely enhanced the innovative processes within their projects.

Conclusion

Susan Elizabeth Napier's contributions to pharmaceutical inventions demonstrate her commitment to advancing medical science. Her patents reflect a dedication to developing new therapies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…